Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Nervous system disorders
ADR ID BADD_A03031
ADR Hierarchy
17      Nervous system disorders
Description Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. [MeSH]
MedDRA Code 10029205
MeSH ID D009422
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Nervous System Diseases | Disease, Nervous System | Diseases, Nervous System | Nervous System Disease | Neurologic Disorders | Disorder, Neurologic | Disorders, Neurologic | Neurologic Disorder | Neurological Disorders | Disorder, Neurological | Disorders, Neurological | Neurological Disorder | Nervous System Disorders | Disorder, Nervous System | Disorders, Nervous System | Nervous System Disorder
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00535Crizotinib0.020561%
BADD_D00536Crofelemer--
BADD_D00537Cromoglycate--
BADD_D00538Cromolyn--
BADD_D00541Cupric chloride--
BADD_D00542Cyanocobalamin0.001007%
BADD_D00543Cyclizine--
BADD_D00544Cyclo-upup--
BADD_D00545Cyclobenzaprine0.001267%
BADD_D00546Cyclobenzaprine hydrochloride--
BADD_D00547Cyclopentolate0.036236%
BADD_D00548Cyclopentolate hydrochloride--
BADD_D00549Cyclophosphamide--
BADD_D00550Cycloserine--
BADD_D00551Cyclosporine0.016366%
BADD_D00552Cyproheptadine--
BADD_D00553Cyproheptadine hydrochloride--
BADD_D00554Cyproterone--
BADD_D00555Cyproterone acetate--
BADD_D00556Cysteamine0.001699%
BADD_D00557Cysteamine bitartrate--
BADD_D00558Cysteamine hydrochloride--
BADD_D00560Cytarabine0.011047%
BADD_D00561Cytarabine hydrochloride--
BADD_D00562Cytomegalovirus immune globulin (human)--
BADD_D00563Dabigatran0.677675%
BADD_D00564Dabigatran etexilate--
BADD_D00566Dabrafenib0.007779%
BADD_D00567Dabrafenib mesylate--
BADD_D00568Dacarbazine0.000526%
The 17th Page    First    Pre   17 18 19 20 21    Next   Last    Total 80 Pages
ADReCS-Target
ADR Term Drug Name Target